| Erin Elizabeth Hanks, CNM | |
|
3129 Springbank Ln Ste 100, Charlotte, NC 28226-3379 | |
| (704) 316-2021 | |
| (704) 316-1675 |
| Full Name | Erin Elizabeth Hanks |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 3129 Springbank Ln Ste 100, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467056416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 183057 (North Carolina) | Secondary |
| 367A00000X | Advanced Practice Midwife | 776 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin Elizabeth Hanks, CNM Po Box 60447, Charlotte, NC 28260-0447 Ph: () - | Erin Elizabeth Hanks, CNM 3129 Springbank Ln Ste 100, Charlotte, NC 28226-3379 Ph: (704) 316-2021 |
News Archive
Aniak, Alaska, is a Yu'pik village of 500 people on the Yukon-Kuskokwim delta, about 400 miles northwest of Anchorage. It is in this special and isolated community where I practice as a dental therapist, trained and certified to deliver some, but not all, types of dental care. Dental therapists have been practicing in Alaska for nine years and now provide routine dental care to 40,000 Native Alaskans. In the United States about forty-seven million people live in areas where there is a shortage of dentists, and millions more can't afford to see them. For so many Americans, even the most basic dental care is out of reach. Yet right here in Alaska, I think we've found part of the solution (Conan Murat, November, 2013).
Scientists using a powerful new technology that sequences RNA in 20,000 individual cell nuclei have uncovered new insights into biological events in heart disease.
XenoPort, Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Research to support a preclinical study of the efficacy and safety of a novel, orally administered prodrug of acamprosate in reducing L-Dopa induced dyskinesias (LID) in a pre-clinical model of Parkinson's disease.
A selection of health policy stories from Virginia, California, Colorado, Missouri, Pennsylvania, Kansas and Texas.
The use of atypical antipsychotics to treat elderly patients with dementia appears to have decreased following a 2005 Food and Drug Administration (FDA) advisory regarding the risks of these medications in this population, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 3 days ago